These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. McCann UD; Szabo Z; Scheffel U; Dannals RF; Ricaurte GA Lancet; 1998 Oct; 352(9138):1433-7. PubMed ID: 9807990 [TBL] [Abstract][Full Text] [Related]
26. Effects of MDMA (ecstasy) use and abstention on serotonin neurons. Ratzenböck E Lancet; 2002 May; 359(9317):1617; author reply 1617-8. PubMed ID: 12047990 [No Abstract] [Full Text] [Related]
27. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence. Meyer JS; Piper BJ; Vancollie VE Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859 [TBL] [Abstract][Full Text] [Related]
28. Effects of MDMA (ecstasy) use and abstention on serotonin neurons. Haddad PM; Strickland P; Anderson I; Deakin JF; Dursun SM Lancet; 2002 May; 359(9317):1616-7; author reply 1617-8. PubMed ID: 12047989 [No Abstract] [Full Text] [Related]
29. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users. Parrott AC Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456 [TBL] [Abstract][Full Text] [Related]
30. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. Reneman L; de Win MM; van den Brink W; Booij J; den Heeten GJ J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475 [TBL] [Abstract][Full Text] [Related]
31. In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain. Scheffel U; Szabo Z; Mathews WB; Finley PA; Dannals RF; Ravert HT; Szabo K; Yuan J; Ricaurte GA Synapse; 1998 Jun; 29(2):183-92. PubMed ID: 9593108 [TBL] [Abstract][Full Text] [Related]
32. Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density. McGregor IS; Clemens KJ; Van der Plasse G; Li KM; Hunt GE; Chen F; Lawrence AJ Neuropsychopharmacology; 2003 Aug; 28(8):1472-84. PubMed ID: 12700695 [TBL] [Abstract][Full Text] [Related]
33. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice. Itzhak Y; Ali SF; Achat CN; Anderson KL Psychopharmacology (Berl); 2003 Mar; 166(3):241-8. PubMed ID: 12590354 [TBL] [Abstract][Full Text] [Related]
34. RETRACTED: Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy"). Ricaurte GA; Yuan J; Hatzidimitriou G; Cord BJ; McCann UD Science; 2002 Sep; 297(5590):2260-3. PubMed ID: 12351788 [TBL] [Abstract][Full Text] [Related]
35. Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study. Chang L; Grob CS; Ernst T; Itti L; Mishkin FS; Jose-Melchor R; Poland RE Psychiatry Res; 2000 Feb; 98(1):15-28. PubMed ID: 10708923 [TBL] [Abstract][Full Text] [Related]
36. Neuroimaging research in human MDMA users: a review. Cowan RL Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678 [TBL] [Abstract][Full Text] [Related]
37. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users. Di Iorio CR; Watkins TJ; Dietrich MS; Cao A; Blackford JU; Rogers B; Ansari MS; Baldwin RM; Li R; Kessler RM; Salomon RM; Benningfield M; Cowan RL Arch Gen Psychiatry; 2012 Apr; 69(4):399-409. PubMed ID: 22147810 [TBL] [Abstract][Full Text] [Related]
38. MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities. Boot BP; Mechan AO; McCann UD; Ricaurte GA Eur J Pharmacol; 2002 Oct; 453(2-3):239-44. PubMed ID: 12398910 [TBL] [Abstract][Full Text] [Related]
39. (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. Wang X; Baumann MH; Xu H; Morales M; Rothman RB J Pharmacol Exp Ther; 2005 Sep; 314(3):1002-12. PubMed ID: 15937150 [TBL] [Abstract][Full Text] [Related]